Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers - 09/01/20

Michele Z. Magnino, MD ^{a, b}, David J. Perry, MD ^{c, d}, Deepa S. Subramaniam, MD ^e, Cynthia M.C. DeKlotz, MD ^{a, f, ⁎}

^a Department of Dermatology, MedStar Georgetown University Hospital/MedStar Washington Hospital Center, Washington, DC 

^b Department of Internal Medicine, MedStar Georgetown University Hospital/MedStar Washington Hospital Center, Washington, DC 

^c Department of Oncology, MedStar Washington Hospital Center, Washington, DC 

^d Washington Cancer Institute, Washington, DC 

^e Department of Oncology, MedStar Georgetown University Hospital and Lombardi Cancer Center, Washington, DC 

^f Department of Medicine and Pediatrics, Georgetown University School of Medicine, Washington, DC 

^∗Reprint requests: Cynthia M. C. DeKlotz, MD, 5530 Wisconsin Ave, Chevy Chase, MD 208155530 Wisconsin AveChevy ChaseMD20815